Your browser doesn't support javascript.
loading
Ethnic differences in hepatitis A and E virus seroprevalence in patients attending the Emergency Department, Paramaribo, Suriname.
Mac Donald-Ottevanger, M S; Prins, Maria; van Dissel, Jaap; Rier, Neela; Reimerink, Johan; Zijlmans, Wilco C W R; Vreden, Stephen G S; Boyd, Anders.
Afiliação
  • Mac Donald-Ottevanger MS; Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam 1105 AZ, The Netherlands.
  • Prins M; Scientific Research Center Suriname, Academic Hospital Paramaribo, Paramaribo, Suriname.
  • van Dissel J; Public Health Service of Amsterdam, Department of Infectious Diseases, Amsterdam 1018 WT, The Netherlands.
  • Rier N; Amsterdam UMC, Department of Infectious Diseases, Amsterdam Infection and Immunity (AII), University of Amsterdam, Amsterdam 1105 AZ, The Netherlands.
  • Reimerink J; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven 3720 BA, The Netherlands.
  • Zijlmans WCWR; Department of Medical Microbiology, Academic Hospital Paramaribo, Paramaribo, Suriname.
  • Vreden SGS; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven 3720 BA, The Netherlands.
  • Boyd A; Faculty of Medical Sciences, Anton de Kom University of Suriname, Paramaribo, Suriname.
Trans R Soc Trop Med Hyg ; 117(3): 197-204, 2023 03 01.
Article em En | MEDLINE | ID: mdl-36353973
ABSTRACT

BACKGROUND:

Hepatitis A virus (HAV) and hepatitis E virus (HEV) have enteric modes of transmission and are common causes of acute hepatitis in low- and middle-income countries. HEV is also characterised as a zoonotic infection and is prevalent in high-income countries. Data on HAV and HEV prevalence in Suriname, a middle-income country in South America, are scarce.

METHODS:

Serum samples of 944 and 949 randomly selected patients attending the Emergency Department at the Academic Hospital of Paramaribo, the capital of Suriname, were analysed for anti-HAV antibodies (anti-HAV) and anti-HEV antibodies (anti-HEV), respectively. Determinants of anti-HAV and anti-HEV positive serology were evaluated using multivariable logistic regression.

RESULTS:

Anti-HAV prevalence was 58.3% (95% CI 55.4 to 61.4%) and higher prevalence was independently associated with belonging to the Tribal or Indigenous population and older age. Anti-HEV prevalence was 3.7% (95% CI 2.6 to 5.0%) and higher prevalence was associated with Tribal and Creole ethnicity and older age.

CONCLUSIONS:

In Suriname, exposure to HAV is consistent with a very low endemic country and exposure to HEV was rare. Both viruses were more prevalent in specific ethnic groups. As anti-HAVantibodies were less frequently found in younger individuals, they could be susceptible to potential HAV outbreaks and might require HAV vaccination.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Hepatite E / Hepatite E / Vírus da Hepatite A / Hepatite A Tipo de estudo: Risk_factors_studies Limite: Humans País como assunto: America do sul / Caribe ingles / Suriname Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Hepatite E / Hepatite E / Vírus da Hepatite A / Hepatite A Tipo de estudo: Risk_factors_studies Limite: Humans País como assunto: America do sul / Caribe ingles / Suriname Idioma: En Ano de publicação: 2023 Tipo de documento: Article